Nuzenio

Marketbeat Maplight Therapeutics

Marketbeat Maplight Therapeutics entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 6 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Timeline

Fri, 07 Aug 2026 16:50:32 GMTMaplight Therapeutics (NASDAQ:MPLT) Shares Down 6.4% - Time to Sell? - MarketBeat
Wed, 05 Aug 2026 01:59:10 GMTMaplight Therapeutics (NASDAQ:MPLT) Insider Sells 22,082 Shares of Stock - MarketBeat
Thu, 30 Jul 2026 07:00:00 GMTMaplight Therapeutics, Inc. (NASDAQ:MPLT) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Wed, 29 Jul 2026 07:18:09 GMTADAR1 Capital Management LLC Purchases New Position in Maplight Therapeutics, Inc. $MPLT - MarketBeat
Wed, 29 Jul 2026 07:00:00 GMTMaplight Therapeutics (NASDAQ:MPLT) Shares Up 18.2% Following Insider Buying Activity - MarketBeat
Tue, 28 Jul 2026 07:00:00 GMTMorgan Stanley Reaffirms "Equal Weight" Rating for Maplight Therapeutics (NASDAQ:MPLT) - MarketBeat

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Marketbeat Maplight Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.